Why Is Merck Stock Trading Higher On Wednesday?

Tuesday, the FDA approved Merck & Co Inc’s MRK Winrevair (sotatercept-csrk), for injection, 45mg, 60mg for adults with pulmonary arterial hypertension (PAH) to increase exercise capacity, improve WHO functional class (FC), and reduce the risk of clinical worsening events. PAH is high blood…#fda #merckcoincs #pah #fc #merck #acceleronpharmainc #winrevair #healthcare #schott
Source: Reuters: Health - Category: Consumer Health News Source Type: news